Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/104.D7q0jHs_.js ...

Illinois cannabis sales exceeded $2 billion in 2024, a 2.5% increase from the previous year. Tax revenue from dispensaries ...

A high-yielding dividend stock can be a great investment -- until it isn't. Just ask Walgreens Boots Alliance shareholders, ...

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis ...

Innovative Industrial Properties has a solid payout ratio and high yield. Find out why IIPR stock’s short-term resistance ...

DoorDash enters the cannabis-adjacent market with hemp-derived THC & CBD delivery. Is this a stepping stone for full-scale ...

Enterprise Group makes the TSX top percentage gainers list today, currently trading at $2.5000, up .1900, gaining 8.2251% on ...